LifeMine Therapeutics Company
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Founded Date:
2016-01-01
Total Funding:
295000000.0
Employee Number:
51-100
Funding Status:
Late Stage Venture
Technology:
['BioTech & HealthTech']
Last Funding Type:
Series C
Investors Number:
14.0
Last Funding Date:
2022-03-23
Industry:
Medical BioTech
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
$1M to $10M